Literature DB >> 6628509

CSF penetration and pharmacokinetics of midazolam.

S Sjövall, J Kanto, J J Himberg, M Hovi-Viander, M Salo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6628509     DOI： 10.1007/bf00543799

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  24 in total

1.  A water-soluble benzodiazepine, RO21-3981, for induction of anesthesia.

Authors:  R J Fragen; F Gahl; N Caldwell
Journal:  Anesthesiology       Date:  1978-07       Impact factor: 7.892

2.  Cerebrospinal fluid concentrations and serum protein binding of lorazepam and its conjugate.

Authors:  L Aaltonen; J Kanto; M Salo
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1980-02

3.  Metabolism of lorazepam.

Authors:  H W Elliott
Journal:  Br J Anaesth       Date:  1976-10       Impact factor: 9.166

Review 4.  Pharmacology of midazolam.

Authors:  L Pieri; R Schaffner; R Scherschlicht; P Polc; J Sepinwall; A Davidson; H Möhler; R Cumin; M Da Prada; W P Burkard; H H Keller; R K Müller; M Gerold; M Pieri; L Cook; W Haefely
Journal:  Arzneimittelforschung       Date:  1981

5.  Midazolam kinetics.

Authors:  H Allonen; G Ziegler; U Klotz
Journal:  Clin Pharmacol Ther       Date:  1981-11       Impact factor: 6.875

6.  The pharmacokinetics of midazolam in man.

Authors:  M T Smith; M J Eadie; T O Brophy
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

7.  Plasma and cerebrospinal fluid concentrations of chlordiazepoxide and its metabolites in surgical patients.

Authors:  D R Stanski; D J Greenblatt; A Selwyn; R I Shader; K Franke; J Koch-Weser
Journal:  Clin Pharmacol Ther       Date:  1976-11       Impact factor: 6.875

8.  [Pharmacokinetics of midazolam after i.v. administration (author's transl)].

Authors:  R Amrein; J P Cano; M Eckert; P Coassolo
Journal:  Arzneimittelforschung       Date:  1981

9.  Cerebrospinal-fluid concentrations of nitrazepam in man.

Authors:  L Kangas; J Kanto; T Siirtola; A Pekkarinen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-07

10.  Diazepam and N-desmethyldiazepam concentrations in saliva, plasma and CSF.

Authors:  C Hallstrom; M H Lader
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335
View more
  7 in total

Review 1.  Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.

Authors:  W A Colburn; M L Jack
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

2.  Pharmacokinetic design optimization in children and estimation of maturation parameters: example of cytochrome P450 3A4.

Authors:  Marion Bouillon-Pichault; Vincent Jullien; Caroline Bazzoli; Gérard Pons; Michel Tod
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-04       Impact factor: 2.745

3.  Chronopharmacokinetic study with prolonged infusion of midazolam.

Authors:  U Klotz; I W Reimann
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

Review 4.  Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes.

Authors:  E Rey; J M Tréluyer; G Pons
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

Review 5.  Pharmacokinetics of the newer benzodiazepines.

Authors:  P D Garzone; P D Kroboth
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

6.  Pharmacokinetics and pharmacodynamics of midazolam in the enflurane-anesthetized dog.

Authors:  R I Hall; F Szlam; C C Hug
Journal:  J Pharmacokinet Biopharm       Date:  1988-06

Review 7.  Midazolam. A review of its pharmacological properties and therapeutic use.

Authors:  J W Dundee; N J Halliday; K W Harper; R N Brogden
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.